The board of directors of Sino-Life Group Limited announce that Dr. XU Qiang ("Dr. Xu") has been re-designated from the non-executive Director to an executive Director (the "Redesignation") and appointed as the chief executive officer of the Company (the "CEO") with effect from 22 January 2021. Following the Redesignation, the Board comprises six members with three executive Directors and three independent non-executive Directors. Dr. Xu, age 43, was appointed as a non-executive Director on 1 March 2019. Since 2012, Dr. Xu has served successively as Product Manager, Director of Application and is now the Vice President of Business Development in a nanotechnology company, focusing on the development of electron microscope related products, in the Netherlands.